About Crestor Crestor was marketed by AstraZeneca to treat high cholesterol and prevent cardiovascular disease. Rosuvastatin was also sold under the trade name R2. Crestor has been scientifically linked to serious side effects.
Crestor is for people with high LDL cholesterol, high total cholesterol, and triglycerides. In February 2010, the FDA also approved Crestor to prevent cardiovascular events.
Crestor can result in serious injuries such as heart attacks and heart failure. Other side effects include cardiomyopathy (deterioration of the myocardium), rhabdomyolysis (breakdown of muscle fibers), and ventricular dysfunction.
Based on these and other serious side effects, in 2004, a consumer advocacy group filed a petition with the FDA, suggesting that Crestor be removed from the market. In addition, an article in the medical journal The Lancet criticized the marketing tactics used to introduce the drug, as well as the data supporting its efficacy.
Help If You’ve Been Injured by Crestor
At O’Hanlon, McCollom & Demerath, our attorneys understand that your cardiovascular injuries may not be your fault – instead, possibly a dangerous side effect of Crestor. Our expertise and experience, combined with our highly trained staff, make us uniquely well-equipped to handle even the most complex products liability claims.
For preliminary questions about your Crestor case, please see our Frequently Asked Questions page. If you suspect you’ve had a Crestor injury such as a heart attack or heart failure, and need to talk to a seasoned team of professionals, please contact us immediately for a free consultation.